<?xml version="1.0" encoding="UTF-8"?>
<p>As a part of our ongoing research on searching the potent biological molecules against various diseases by 
 <italic>in silico</italic> and wet laboratory methods (Kalirajan et al., 
 <xref rid="CIT0027" ref-type="bibr">2011</xref>; Kalirajan, Kulshrestha, et al., 
 <xref rid="CIT0021" ref-type="bibr">2012</xref>; Kalirajan, Mohammed Rafick, et al., 
 <xref rid="CIT0022" ref-type="bibr">2012</xref>; Kalirajan et al., 
 <xref rid="CIT0025" ref-type="bibr">2013</xref>; Kalirajan, Gowramma, et al., 
 <xref rid="CIT0019" ref-type="bibr">2017</xref>; Kalirajan, Sankar, et al., 
 <xref rid="CIT0028" ref-type="bibr">2017</xref>; Kalirajan, Kulshrestha, et al., 
 <xref rid="CIT0020" ref-type="bibr">2018</xref>; Kalirajan, Mohammed Rafick, et al., 
 <xref rid="CIT0023" ref-type="bibr">2018</xref>; Kalirajan, Gaurav, et al., 
 <xref rid="CIT0018" ref-type="bibr">2019</xref>; Kalirajan, Pandiselvi, et al., 
 <xref rid="CIT0026" ref-type="bibr">2019</xref>), we have designed and evaluated various heterocyclic compounds for their biological activities. Using different modules (Glide, QikProp, Prime and Desmond) of Schrödinger suite LLC, various computational methods such as molecular docking, ADMET screening, binding free energy calculations and molecular dynamics (MD) simulations were performed to find the interactions responsible for COVID-19 inhibition. These studies will provide the requirement of key structural features in the design of potential drug candidates.
</p>
